HRPMF
Price:
$3.51
Market Cap:
$50.94M
Herantis Pharma Oyj, a biotechnology enterprise, specializes in creating disease-modifying therapies for Parkinson's disease (PD) that harness Cerebral Dopamine Neurotrophic Factor (CDNF). Central to its developmental efforts is HER-096, a sophisticated, compact, synthetic chemical peptidomimetic originating from the active parent molecule. This preclinical xCDNF candidate is currently being investigated for its therapeutic promise in PD and other neurodegenerative conditions. Additionally, the firm is advancing recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is presently undergoing Phase I clinical evaluation in individuals afflicted with Parkinso...[Read more]
Industry
Biotechnology
IPO Date
2018-10-30
Stock Exchange
OTC
Ticker
HRPMF
According to Herantis Pharma Oyj’s latest financial reports and current stock price. The company's current Current Ratio is 2.93. This represents a change of -32.70% compared to the average of 4.35 of the last 4 quarters.
The mean historical Current Ratio of Herantis Pharma Oyj over the last ten years is 3.57. The current 2.93 Current Ratio has changed 8.10% with respect to the historical average. Over the past ten years (40 quarters), HRPMF's Current Ratio was at its highest in in the June 2014 quarter at 18.44. The Current Ratio was at its lowest in in the June 2011 quarter at 0.
Average
3.57
Median
3.59
Minimum
1.69
Maximum
4.72
Discovering the peaks and valleys of Herantis Pharma Oyj Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 113.86%
Maximum Annual Current Ratio = 4.72
Minimum Annual Increase = -55.35%
Minimum Annual Current Ratio = 1.69
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.93 | -27.86% |
| 2024 | 4.06 | 19.60% |
| 2023 | 3.39 | 3.46% |
| 2022 | 3.28 | -8.10% |
| 2021 | 3.57 | -23.83% |
| 2020 | 4.68 | 29.87% |
| 2019 | 3.61 | 113.86% |
| 2018 | 1.69 | -55.35% |
| 2017 | 3.78 | -20.04% |
| 2016 | 4.72 | -51.69% |
The current Current Ratio of Herantis Pharma Oyj (HRPMF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.46
5-year avg
3.44
10-year avg
3.57
Herantis Pharma Oyj’s Current Ratio is less than Oncopeptides AB (publ) (4.55), greater than Biostage, Inc. (0.53), greater than Mindset Pharma Inc. (1.18), greater than Goodness Growth Holdings, Inc. (1.20), less than Abliva AB (publ) (4.13), less than Karolinska Development AB (publ) (128.29), greater than Elegance Optical International Holdings Limited (0.83), less than Relief Therapeutics Holding AG (0), less than Small Pharma Inc. (5.77), greater than SymBio Pharmaceuticals Limited (1.11),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.55 | $55.98M | |
| 0.53 | $57.82M | |
| 1.18 | $54.51M | |
| 1.20 | $61.05M | |
| 4.13 | $45.13M | |
| 128.29 | $68.85M | |
| 0.83 | $63.38M | |
| 0 | $44.94M | |
| 5.77 | $37.51M | |
| 1.11 | $26.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Herantis Pharma Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Herantis Pharma Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Herantis Pharma Oyj's Current Ratio?
How is the Current Ratio calculated for Herantis Pharma Oyj (HRPMF)?
What is the highest Current Ratio for Herantis Pharma Oyj (HRPMF)?
What is the 3-year average Current Ratio for Herantis Pharma Oyj (HRPMF)?
What is the 5-year average Current Ratio for Herantis Pharma Oyj (HRPMF)?
How does the current Current Ratio for Herantis Pharma Oyj (HRPMF) compare to its historical average?